Using a Jurkat reporter cell line, we then demonstrate that EVs shed from glioma cells are capable of inhibiting TCR signaling in a dose-dependent manner with this effect being most pronounced when vesicles are shed from cells that lack PTEN. The gene discussed is PTEN; the disease is glioma.